Seven major pharmaceutical companies including Eli Lilly and Regeneron are breaking ground on new U.S. manufacturing facilities this summer under Trump’s PreCheck Pilot Program. The initiative aims to reduce approval delays that previously took up to 14 months, bringing thousands of high-wage jobs back home.

Read More